Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis

Journal of Crohn's and Colitis

Volumn 8, Issue 7, 2014, Pages 693-701

  Kim, Jong Wook ^a   Boo, Sun Jin ^b   Ye, Byong Duk ^c   Kim, Chang Lae ^c   Yang, Suk Kyun ^c   Kim, Jihun ^c   Kim, Sun A ^c   Park, Sang Hyoung ^c   Park, Soo Kyung ^c   Yang, Dong Hoon ^c   Jung, Kee Wook ^c   Kim, Kyung Jo ^c   Byeon, Jeong Sik ^c   Myung, Seung Jae ^c   Kim, Jin Ho ^c  

^a Inje University   (South Korea)

^b Jeju National University School of Medicine   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

Antigenemia assay; Cytomegalovirus; Polymerase chain reaction; Ulcerative colitis

Indexed keywords

CORTICOSTEROID; EOSIN; GANCICLOVIR; HEMATOXYLIN; INFLIXIMAB; MERCAPTOPURINE; TUMOR NECROSIS FACTOR INHIBITOR; VIRUS DNA; VIRUS ANTIGEN;

ADULT; ARTICLE; ASSAY; BLOOD; COLITIS; COLON RESECTION; CORTICOSTEROID THERAPY; CYTOMEGALOVIRAL COLITIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS ANTIGENEMIA ASSAY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIDDLE AGED; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STAINING; ULCERATIVE COLITIS; AREA UNDER THE CURVE; COLITIS, ULCERATIVE; COMPLICATION; CYTOMEGALOVIRUS INFECTIONS; GENETICS; IMMUNOLOGY; VIROLOGY;

ADULT; ANTIGENS, VIRAL; AREA UNDER CURVE; COLECTOMY; COLITIS, ULCERATIVE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84901491965     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.12.014     Document Type: Article

References (40)

1. Colomba C., Lalicata F., Siracusa L., Di Bona D., Giammanco G., De Grazia S., et al. Cytomegalovirus infection in immunocompetent patients. Clinical and immunological considerations. Infez Med 2012, 20:12-15.
2. Gallant J.E., Moore R.D., Richman D.D., Keruly J., Chaisson R.E. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis 1992, 166:1223-1227.
3. Mori T., Mori S., Kanda Y., Yakushiji K., Mineishi S., Takaue Y., et al. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2004, 33:431-434.
4. Kim C.H., Bahng S., Kang K.J., Ku B.H., Jo Y.C., Kim J.Y., et al. Cytomegalovirus colitis in patients without inflammatory bowel disease: a single center study. Scand J Gastroenterol 2010, 45:1295-1301.
5. Cottone M., Pietrosi G., Martorana G., Casa A., Pecoraro G., Oliva L., et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001, 96:773-775.
6. Domenech E., Vega R., Ojanguren I., Hernandez A., Garcia-Planella E., Bernal I., et al. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis 2008, 14:1373-1379.
7. Maher M.M., Nassar M.I. Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease. Dig Dis Sci 2009, 54:2456-2462.
8. Papadakis K.A., Tung J.K., Binder S.W., Kam L.Y., Abreu M.T., Targan S.R., et al. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol 2001, 96:2137-2142.
9. Kaufman H.S., Kahn A.C., Iacobuzio-Donahue C., Talamini M.A., Lillemoe K.D., Hamilton S.R. Cytomegaloviral enterocolitis: clinical associations and outcome. Dis Colon Rectum 1999, 42:24-30.
10. Rahier J.F., Ben-Horin S., Chowers Y., Conlon C., De Munter P., D'Haens G., et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2009, 3:47-91.
11. Lawlor G., Moss A.C. Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander?. Inflamm Bowel Dis 2010, 16:1620-1627.
12. Nakase H., Yoshino T., Matumura K., Honzawa Y., Yamamoto S., Matsuura M., et al. Positive finding of colonic polymerase chain reaction for cytomegalovirus DNA is not false positive but a warning for treating patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis 2011, 17:E13-E14.
13. Drew W.L. Diagnosis of cytomegalovirus infection. Rev Infect Dis 1988, 10(Suppl. 3):S468-S476.
14. Goodgame R.W. Gastrointestinal cytomegalovirus disease. Ann Intern Med 1993, 119:924-935.
15. Kambham N., Vij R., Cartwright C.A., Longacre T. Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am J Surg Pathol 2004, 28:365-373.
16. Almeida N., Romaozinho J.M., Amaro P., Ferreira M., Cipriano M.A., Leitao M.C. Fatal mid-gastrointestinal bleeding by cytomegalovirus enteritis in an immunocompetent patient. Acta Gastroenterol Belg 2009, 72:245-248.
17. Frank D., Raicht R.F. Intestinal perforation associated with cytomegalovirus infection in patients with acquired immune deficiency syndrome. Am J Gastroenterol 1984, 79:201-205.
18. Nagata N., Kobayakawa M., Shimbo T., Hoshimoto K., Yada T., Gotoda T., et al. Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromised patients. World J Gastroenterol 2011, 17:1185-1191.
19. Michaelides A., Liolios L., Glare E.M., Spelman D.W., Bailey M.J., Walters E.H., et al. Increased human cytomegalovirus (HCMV) DNA load in peripheral blood leukocytes after lung transplantation correlates with HCMV pneumonitis. Transplantation 2001, 72:141-147.
20. Moon S.M., Sung H., Kim M.N., Lee S.O., Choi S.H., Kim Y.S., et al. Diagnostic yield of the cytomegalovirus (CMV) antigenemia assay and clinical features in solid organ transplant recipients and hematopoietic stem cell transplant recipients with CMV pneumonia. Transpl Infect Dis 2012, 14:192-197.
21. Greanya E.D., Partovi N., Yoshida E.M., Shapiro R.J., Levy R.D., Sherlock C.H., et al. The role of the cytomegalovirus antigenemia assay in the detection and prevention of cytomegalovirus syndrome and disease in solid organ transplant recipients: a review of the British Columbia experience. Can J Infect Dis Med Microbiol 2005, 16:335-341.
22. Gimeno C., Solano C., Latorre J.C., Hernandez-Boluda J.C., Clari M.A., Remigia M.J., et al. Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients. J Clin Microbiol 2008, 46:3311-3318.
23. Jang E.Y., Park S.Y., Lee E.J., Song E.H., Chong Y.P., Lee S.O., et al. Diagnostic performance of the cytomegalovirus (CMV) antigenemia assay in patients with CMV gastrointestinal disease. Clin Infect Dis 2009, 48:e121-e124.
24. Schroeder K.W., Tremaine W.J., Ilstrup D.M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987, 317:1625-1629.
25. Omiya M., Matsushita M., Tanaka T., Kawamata S., Okazaki K. The absence of large ulcer predicts latent cytomegalovirus infection in ulcerative colitis with positive mucosal viral assay. Intern Med 2010, 49:2277-2282.
26. Blackstone M.O. Differentiation of ulcerative colitis from Crohn's colitis. Endoscopic interpretation: normal and pathologic appearance of the gastrointestinal tract 1984, 464-496. Raven Press, New York.
27. Colombel J.F., Loftus E.V., Tremaine W.J., Pemberton J.H., Wolff B.G., Young-Fadok T., et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004, 99:878-883.
28. Preiksaitis J.K., Brennan D.C., Fishman J., Allen U. Canadian Society of Transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant 2005, 5:218-227.
29. Mills A.M., Guo F.P., Copland A.P., Pai R.K., Pinsky B.A. A comparison of CMV detection in gastrointestinal mucosal biopsies using immunohistochemistry and PCR performed on formalin-fixed, paraffin-embedded tissue. Am J Surg Pathol 2013, 37:995-1000.
30. Mendez J., Espy M., Smith T.F., Wilson J., Wiesner R., Paya C.V. Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation. Transplantation 1998, 65:1477-1481.
31. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
32. Yoshino T., Nakase H., Ueno S., Uza N., Inoue S., Mikami S., et al. Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis 2007, 13:1516-1521.
33. Baroco A.L., Oldfield E.C. Gastrointestinal cytomegalovirus disease in the immunocompromised patient. Curr Gastroenterol Rep 2008, 10:409-416.
34. Galiatsatos P., Shrier I., Lamoureux E., Szilagyi A. Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. Dig Dis Sci 2005, 50:609-616.
35. Kandiel A., Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol 2006, 101:2857-2865.
36. Matsuoka K., Iwao Y., Mori T., Sakuraba A., Yajima T., Hisamatsu T., et al. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol 2007, 102:331-337.
37. Leveque N., Brixi-Benmansour H., Reig T., Renois F., Talmud D., Brodard V., et al. Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases. J Med Virol 2010, 82:1694-1700.
38. Roblin X., Pillet S., Oussalah A., Berthelot P., Del Tedesco E., Phelip J.M., et al. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol 2011, 106:2001-2008.
39. Kornbluth A., Sachar D.B. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2004, 99:1371-1385.
40. Suzuki H., Kato J., Kuriyama M., Hiraoka S., Kuwaki K., Yamamoto K. Specific endoscopic features of ulcerative colitis complicated by cytomegalovirus infection. World J Gastroenterol 2010, 16:1245-1251.